A Single-Arm Study Evaluating the Efficacy of Liquid Acupuncture Therapeutics in Chronic Hepatitis B
NCT00815464 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2008-12-30
Summary
Study Purpose:
The purpose of this study is to assess that Liquid Acupuncture(Herb Acupoints Injection) Therapeutics could achieve permanent efficacy response in Chronic Hepatitis B.
Efficacy Assessment:
At cessation of the Treatment(about at 24 weeks)comparing Testing Data with the Normal Criteria and their individual baseline.Continue for monitoring the Status 1-5 years.
Data Analysis:
Each 4 weeks collecting Patients' testing data and fill a table.A summary table will be presented as frequency tables for categorical variables as number or percentage.
Conditions
- Hepatitis B, Chronic
- Liver Diseases
- Virus Diseases
- Hepatitis
- Diffuse Hepatic Disease
Interventions
- DEVICE
-
Liquid Acupuncture (Herb Acupoint Injection)
Each 4 weeks per one circle.The first 3 weeks for treatment practice(one per week)and the last week for test collection.
Sponsors & Collaborators
-
Yu Medical Garden
lead OTHER
Principal Investigators
-
Ke Heng Yu · Yu Medical Garden
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-03-31
- Primary Completion
- 2009-09-30
- Completion
- 2010-03-31
More Related Trials
-
A Clinical Study on Therapeutic Double-plasmid Hepatitis B Virus (HBV) DNA Vaccine in Patients With HBeAg-positive Chronic Hepatitis B
NCT01189656 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of AHB-137 in Participants With Chronic Hepatitis B (CHB) Treated With Nucleos(t)Ide Analogues (NAs)(AUSHINE)
NCT07246889 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) Combined With Nucleoside (Acid) Analogues in Chronic Hepatitis B Patients
NCT04189276 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) in Chronic Hepatitis B Patients
NCT04168333 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Efficacy and Safety of AHB-137 in Treatment-naive Participants With Chronic Hepatitis B (CHB)
NCT06829329 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB).
NCT06550128 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Efficacy and Economic Evaluation of Nonbiological Artificial Liver Therapy in Acute-on-chronic Hepatitis B Liver Failure.
NCT05392673 ·Status: COMPLETED ·Phase: NA
-
Study of LW231 in Participants With Chronic Hepatitis B
NCT07179575 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Plasma Purification and Chronic Hepatitis B
NCT04518553 ·Status: UNKNOWN ·Phase: NA
-
A Mechanistic Study of GSK3228836 With Fine Needle Aspiration (FNA) in Participants With Chronic Hepatitis B
NCT04544956 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB)
NCT07137910 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of Dual-plasmid Hepatitis B Virus DNA Vaccine in Chronic Hepatitis B Patients
NCT01487876 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of the Cellular Response Induced After Vaccination Against the Hepatitis B Virus
NCT06876467 ·Status: RECRUITING
-
Phase 1 Study of 162, a Novel Neutralizing Antibody Targeting Hepatitis B Surface Antigen, in Healthy Adult Subjects
NCT05310487 ·Status: COMPLETED ·Phase: PHASE1
-
Safety Study of HBV DNA Vaccine to Treat Patients With Chronic Hepatitis B Infection
NCT00277576 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 2 Trial of Therapeutic Hepatitis B Vaccine (Mimogen-based) for Chronic Hepatitis B
NCT00869778 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study of HT-101 and/or HT-102 in Patients With Chronic Hepatitis B Virus Infection
NCT07183306 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
The Curative Effect and Security of Interferon Combined Resveratrol on HBeAg Positive Chronic Hepatitis B Patients
NCT03546530 ·Status: COMPLETED ·Phase: NA
-
A Study of ALN-HBV in Healthy Adult Volunteers and Non-cirrhotic Patients With Chronic Hepatitis B Virus (HBV) Infection
NCT02826018 ·Status: TERMINATED ·Phase: PHASE1
-
Clinical Trials of the Hepatitis B Sandwich Combination Therapy for Treating Patients Infected With Hepatitis B Virus
NCT07088133 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study of ABI-H2158 in Healthy Volunteers and Patients With Chronic Hepatitis B
NCT03714152 ·Status: COMPLETED ·Phase: PHASE1
-
The Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines
NCT01949857 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Safety, Tolerability of HH-003 Injection in Participants With Chronic Hepatitis B Virus Infection
NCT05542979 ·Status: COMPLETED ·Phase: PHASE1
-
HBV-Specific TCR-T Cell Therapy Combined With Nucleos(t)Ide Analogues in Chronic Hepatitis B Patients
NCT06885710 ·Status: RECRUITING ·Phase: PHASE1
-
The Clinical Trial of the Anti Hepatitis B Placenta Transfer Factor Injection
NCT02412319 ·Status: UNKNOWN ·Phase: PHASE4